Literature DB >> 25091432

Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases.

Hugo González1, Daniela Elgueta2, Andro Montoya1, Rodrigo Pacheco3.   

Abstract

Neuroinflammation constitutes a fundamental process involved in the progression of several neurodegenerative disorders, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis and multiple sclerosis. Microglial cells play a central role in neuroinflammation, promoting neuroprotective or neurotoxic microenvironments, thus controlling neuronal fate. Acquisition of different microglial functions is regulated by intercellular interactions with neurons, astrocytes, the blood-brain barrier, and T-cells infiltrating the central nervous system. In this study, an overview of the regulation of microglial function mediated by different intercellular communications is summarised and discussed. Afterward, we focus in T-cell-mediated regulation of neuroinflammation involved in neurodegenerative disorders.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Microglia; Neo-antigens; Neurodegenerative disorders; Neuroinflammation; T-cells

Mesh:

Year:  2014        PMID: 25091432     DOI: 10.1016/j.jneuroim.2014.07.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  112 in total

Review 1.  Immune-mediated processes in neurodegeneration: where do we stand?

Authors:  Marc Fakhoury
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

2.  Artesunate Attenuates Lipopolysaccharide-Stimulated Proinflammatory Responses by Suppressing TLR4, MyD88 Expression, and NF-κB Activation in Microglial Cells.

Authors:  Dunjing Wang; Jun Shi; Shuiqing Lv; Weiwei Xu; Jizhen Li; Wei Ge; Chenghua Xiao; Deqin Geng; Yonghai Liu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

3.  NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction.

Authors:  Lin Xu; Xiaofei Qiu; Shuo Wang; Qingshan Wang; Xiu-Lan Zhao
Journal:  Neurosci Bull       Date:  2018-12-19       Impact factor: 5.203

Review 4.  Neuroinflammation and microglia in glaucoma: time for a paradigm shift.

Authors:  Xin Wei; Kin-Sang Cho; Eric F Thee; Martine J Jager; Dong Feng Chen
Journal:  J Neurosci Res       Date:  2018-05-18       Impact factor: 4.164

Review 5.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.

Authors:  Kristopher G Hooten; David R Beers; Weihua Zhao; Stanley H Appel
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 6.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

7.  Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation.

Authors:  Muskan Gupta; Gurcharan Kaur
Journal:  Neuromolecular Med       Date:  2018-05-30       Impact factor: 3.843

Review 8.  Innate and acquired immune surveillance in the postdissemination phase of metastasis.

Authors:  Hugo Gonzalez; Isabella Robles; Zena Werb
Journal:  FEBS J       Date:  2017-11-24       Impact factor: 5.542

9.  Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses.

Authors:  Rosa Calvello; Antonia Cianciulli; Giuseppe Nicolardi; Francesco De Nuccio; Laura Giannotti; Rosaria Salvatore; Chiara Porro; Teresa Trotta; Maria Antonietta Panaro; Dario Domenico Lofrumento
Journal:  J Neuroimmune Pharmacol       Date:  2016-12-16       Impact factor: 4.147

10.  Effects of epigallocatechin-3-gallate on systemic inflammation-induced cognitive dysfunction in aged rats.

Authors:  Daiki Yamanaka; Takashi Kawano; Atsushi Nishigaki; Bun Aoyama; Hiroki Tateiwa; Marie Shigematsu-Locatelli; Fabricio M Locatelli; Masataka Yokoyama
Journal:  J Anesth       Date:  2017-07-27       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.